Live Breaking News & Updates on Dermavant Sciences|Page 10

Stay updated with breaking news from Dermavant sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis

Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Philip Brown , Henry Ford Health System , Drug Administration , Dermavant Sciences , Stein Gold ,

Roivant Sciences Limited stock pops after positive topline results for its VTAMA cream from the ADORING 2 atopic dermatitis Phase 3 trial

Roivant Sciences Limited saw its shares rise after its subsidiary Dermavant Sciences reported positive topline results from ADORING 2, one of two Phase 3. ....

United States , Long Beach , Philipm Brown , Roivant Sciences , Drug Administration , Dermavant Sciences , Roivant Sciences Limited ,

Vtama cream exhibits 'remarkable results' in atopic dermatitis treatment

Results showed that Vtama cream 1% was safe, effective and well tolerated in a phase 3 study evaluating the cream in adults and children aged as young as 2 years with atopic dermatitis, Dermavant Sciences announced in a press release. “Ninety percent of the medicines that are addressing eczema in the United States are topical steroids,” Todd Zavodnick, CEO at Dermavant Sciences, told ....

United States , Kristen Dowd , Todd Zavodnick , Dermavant Sciences ,

Roivant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old

15.03.2023 - 46.4% of subjects receiving VTAMA cream, 1% achieved the primary endpoint of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-ADTM) response of clear (0) or almost clear (1) with at least a 2-grade improvement from baseline at . Seite 1 ....

Dermavant Sciences , Roivant Sciences Nasdaq , Validated Investigator Global Assessment , Atopic Dermatitis , Roivant Sciences ,